02 December 2025
02 December 2025
As part of the 0% tariff deal, the NHS will pay 25% more for innovative medicines.
While the WHO is still assessing the scale of the impact of foreign aid cuts, access to PrEP medication is believed to have dropped dramatically.
If approved, TSRA-196 could become the first curative therapy to reach patients with AATD.
The NDA submission is based on findings from three randomised, double-masked, controlled Phase III studies carried out in the US.
The designation enables sponsors to receive a paediatric priority review voucher.
With $1.5 billion in drug sales, the US dominated the CKD-HPT, HP and HK market in 2024, representing 59.7% of 7MM sales.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
